Home/Filings/4/0001127602-24-026628
4//SEC Filing

Khosla Rachna 4

Accession 0001127602-24-026628

CIK 0000318154other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 7:46 PM ET

Size

5.5 KB

Accession

0001127602-24-026628

Insider Transaction Report

Form 4
Period: 2024-11-05
Khosla Rachna
SVP, Business Development
Transactions
  • Tax Payment

    Common Stock

    2024-11-05$316.91/sh212$67,1858,383 total
Footnotes (2)
  • [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Plan): 128 RSUs which will vest on 4/30/2025; 398 RSUs which will vest on 11/5/2025; 407 RSUs which will vest in installments of 200 on 5/2/2025, and 207 on 5/2/2026; 593 RSUs which will vest in in installments of 195 on 5/2/2025, 196 on 5/2/2026 and 202 on 5/2/2027; and 532 RSUs which will vest in installments of 175 on 5/7/2026, 176 on 5/7/2027, and 181 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F2]These shares include 129 Dividend Equivalents (DEs) granted pursuant to the Company's Equity Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001881332

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 7:46 PM ET
Size
5.5 KB